Optimizing Phage Cocktails to Fight Antibiotic Resistance

Multidrug‑resistant bacterial infections are increasingly threatening global health, prompting a resurgence of interest in bacteriophage therapy. Phages—viruses that infect and replicate within specific bacteria—offer a targeted alternative to conventional antibiotics, directly lysing pathogenic cells while sparing normal flora.

Recent research has focused on modeling the interactions between phages and bacteria to refine treatment protocols. By simulating the dynamics of phage replication, bacterial growth, and immune responses, scientists can predict how different phage cocktails will perform against particular infections. These models help identify optimal phage combinations, dosages, and timing, thereby increasing the likelihood of therapeutic success and reducing the risk of resistance development.

The application of mathematical modeling represents a critical step toward translating phage therapy from experimental settings to routine clinical practice. As the models become more sophisticated, they promise to guide personalized treatment plans and accelerate the approval of phage‑based interventions for patients facing untreatable bacterial infections.